| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |